Darnitsa is a pharmaceutical company, a leader in Ukrainian market in the production and physical sales of prescription (Rx) and over-the-counter (OTC) generic products. The company began operating in 1930. In 2019, Darnitsa rebranded and announced a new business strategy: to transform based on digital technologies, to build an international brand and to lead in the generic segment of medicines.
The company's portfolio includes 280 names of ready-to-use drugs. Darnitsa focuses on the treatment of cardiac, neurological diseases and pain. Its products are exported to 16 countries.
The Darnitsa plant in Kyiv has 14 production lines certified according to the GMP standard.
Farmak is the leader of pharmaceutical market with a share of 5.9 %. The medicines of all fourteen therapeutic groups are produced at the factory. Among the main areas are anti-cold, endocrinological, gastroenterological, cardiological and neurological portfolios. Every year, Farmak launches approximately 20 new drugs on the market; these are complex modern medications needed by millions of people, both in our country and abroad. About a hundred drugs are currently under development.
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, respiratory diseases.
Orion's main market is Finland, where it is the clear market leader. Orion’s products are marketed in over a hundred countries, and the Group's own human pharmaceuticals sales organization covers almost all key European markets and a few Southeast Asian countries. In other markets Orion’s products are sold by several collaboration partners. All of Orion's manufacturing plants and most of its R&D operations are in Finland. Orion’s headquarters are in Espoo.
«Perrigo is a world leading health company which creates and provides non-prescription (ОТС) and perscription (Rx) medicines, consumer goods, food products and active pharmaceutical ingredients (API). Since 1887, Perrigo has been providing its customers and consumers with high-quality products that support personal health and wellness by delivering effective solutions that meet the needs of consumers almost all over the world – mostly in Northern America, Europe, Australia, and other key markets like Israel and China».
the Company RECORDED GROUPS, with headquarters in Milan (Italy), has offices in many countries of Central and Eastern Europe, in Russia, in Turkey, in North Africa and in the United States of America.